Kai Feng

Statistics

Publications

Citations

344

H-Index

Active since

2012

Affiliations

Shunyi Hospital of Beijing Traditional Chinese Medicine Hospital(Current)

China Pharmaceutical University

Chinese Academy of Medical Sciences & Peking Union Medical College

Sun Yat-sen University

Jiangsu Province Hospital

Kai Feng is an author at Shunyi Hospital of Beijing Traditional Chinese Medicine Hospital specializing in molecular biology, life sciences, and microrna-mediated regulation.

ORCID

Publications per year

2012–2025

Publications

Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway

Yanchun Wei, Yan Wu, Kai Feng et al. · Journal of Ethnopharmacology · 2019 · 95 citations

Life Sciences, Cardiology, Molecular Biology +12

Risk Score to Predict Hospital-Acquired Pneumonia After Spontaneous Intracerebral Hemorrhage

Ruijun Ji, Haipeng Shen, Yuesong Pan et al. · Stroke · 2014 · 68 citations

Pharmacy, Emergency Medicine, Clinical Classification Systems +16

MicroRNA-135a inhibits cardiac fibrosis induced by isoproterenol via TRPM7 channel

Yan Wu, Yonghui Liu, Yitong Pan et al. · Biomedicine & Pharmacotherapy · 2018 · 41 citations

Life Sciences, Molecular Biology, Pharmacology +12

A ROS-responsive hydrogel encapsulated with matrix metalloproteinase-13 siRNA nanocarriers to attenuate osteoarthritis progression

Qiuyang Wang, Kai Feng, Guangsheng Wan et al. · Journal of Nanobiotechnology · 2025 · 34 citations · Full text

Pharmacy, Bioengineering, Biotechnology +17

Cytarabine delivered by CD44 and bone targeting redox-sensitive liposomes for treatment of acute myelogenous leukemia

Hao Wu, Yuan Gao, Jia Ma et al. · Regenerative Biomaterials · 2022 · 22 citations · Full text

Pharmacy, Oncology, Pharmacology +17

1–5 of 11